An Oxford medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has launched the latest version of the company’s award-winning stroke imaging platform.
Last week the company, Brainomix, was also announced as the winner, of an Artificial Intelligence in Health and Care Award by Secretary of State for Health, Matt Hancock, at the Founders Forum HealthTech Summit in London.
The award includes a significant grant that will enable Brainomix to deploy its software, the e-Stroke Suite, across a number of UK stroke networks and evaluate its impact on stroke care across the regions.
The new release incorporates a series of revolutionary AI technologies.
Eric Greveson, Chief Technology Officer at Brainomix, said: “At Brainomix we are focussed on advanced the value of simple imaging, and with these new ground-breaking capabilities, our aim is to employer physicians to make more confident decisions in a timely manner, expanding patient access to life-saving treatments.
Brainomix is an Oxford-based company specialising in the creation of AI-offshoot of the University of Oxford, its e-Stroke Suite provides clinicians with the most comprehensive stroke imaging solution, helping to interpret images and facilitating faster, more confident treatment decision for patients which suspected stokes.